JOANNA BLOOMER: Open Payments
NPI 1407197635 · GREENUP, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,678 in 89 payments from 14 companies in 2025. Trend: 2023 $417 · 2024 $1,438 · 2025 $1,678
Food & beverage: $1,678
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $405 |
| Otsuka America Pharmaceutical, Inc. | 14 | $320 |
| Vanda Pharmaceuticals Inc. | 10 | $268 |
| Alkermes, Inc. | 7 | $157 |
| Janssen Pharmaceuticals, Inc | 8 | $151 |
| Teva Pharmaceuticals USA, Inc. | 6 | $101 |
| Neurocrine BioSciences, Inc. | 4 | $71 |
| Lundbeck LLC | 4 | $67 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $28 |
Products named: VRAYLAR, REXULTI, FANAPT, ARISTADA, INVEGA SUSTENNA, AUSTEDO XR, INGREZZA, HETLIOZ.
Industry payments across KY — which companies pay providers there.
